Tue, 29 Oct 2013 | BUSINESS SALE
A drugs company that specialises in anti-cancer medication has been sold to AstraZeneca.
Founded by a scientist from the University of Portsmouth and a former student, the business – Spirogen Ltd - was born out of research projects that are now approaching fruition.
The firm is developing drugs that target cancer without destroying healthy cells. It has some drugs in Phase II clinical trials, including a DNA binding drug that could be used in the treatment of ovarian cancer and leukaemia.
Spirogen was co-founded in 2000 by David Thurston, who now works as a Professor of Drug Discovery at King's College London. He previously founded the Institute of Biomedical and Biomolecular Sciences (IBBS) with Professor Geoff Kneale.
Professor Kneale commented on the development: “I am delighted that Spirogen has been so successful in developing these novel compounds, first designed and synthesised by Professor Thurston and colleagues here at Portsmouth.
“It is very rewarding when the fundamental research we started in IBBS many years ago is translated into the clinic. It gives me great confidence that much of the research we are currently engaged in will find equally successful clinical applications, with a real impact on people’s lives.”
The sale has gone through for £124 million.
____________________________________________________________________________
Related information:
View the latest medical and educational businesses for sale
Exceptionally successful owner-operated company located in central Scotland, specialising in a niche domestic refurbishment sector with remarkable growth. This specialist operation has experienced extraordinary trading growth, driven by a tight-knit,...
An exciting opportunity to acquire a leading national commercial cleaning service provider with a strong focus in the South-East of the UK. The company’s head office is located at offices in the SE of England.
The company is a provider of residential care homes for young people with behavioural, emotional, and social difficulties resulting from early childhood trauma and adverse life experiences. Services provided by the business are flexible and dynamic,...
LEASEHOLD
28
|
Nov
|
Powertrain specialist Lancereal drives forward with MBO | MBO/MBI
A four decades strong powertrain specialist has undergone a ...
27
|
Nov
|
Debt collectors BPO take out loan to buy rival | BUSINESS SALE
Ayrshire-based debt recovery firm BPO Collections has receiv...
27
|
Nov
|
Brighton i360 looking for new owners | ADMINISTRATION
The company behind Brighton’s i360 viewing pod has fil...
19
|
Feb
|
Pharmaceutical manufacturer enters administration | ADMINISTRATION
A pharmaceutical manufacturing company based in Bristol has ...
Business Sale Report is your complete solution to finding great acquisition opportunities.
Join today to receive:
All this and much more, including the latest M&A news and exclusive resources
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.